Jan C. Buckner, M.D.

  1. Internist
  2. Oncologist
  3. Chair, Oncology, Minnesota
close video

My name is Jan Buckner, I'm a Medical Oncologist at Mayo Clinic. My area of interest is in patients with brain tumors. It's really important to partner with a patient on the decision making. And it's important to understand what the patient's goals are before we even initiate the first therapy. Particularly in the case of brain tumors, we want to make sure that the treatment is not worse than the disease.

The most exciting aspect of my job, by far, is the opportunity to help patients live longer and better lives. The team at Mayo Clinic is incredibly strong. We have the best team of doctors that it's possible to find. Coupled with that is the opportunity to develop new therapies, so that we will have had a role and made a difference, not only for the patients of today, but for the patients of tomorrow, as well.

show transcript

Location

  1. Rochester, Minnesota | Jacksonville, Florida

Languages

English
  1. 1985
    Fellow - Medical OncologyMayo School of Graduate Medical Education, Mayo Clinic in Rochester
  2. 1983
    Resident - Internal MedicineButterworth Hospital
  3. 1980
    MDUniversity of North Carolina, Chapel Hill
  4. 1976
    BA - Chemistry and ReligionWake Forest University

Certifications

  1. 1985
    Medical OncologyAmerican Board of Internal Medicine
  2. 1983
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2016
    Charles G. Moertel, M.D. Memorial LectureshipAlliance for Clinical Trials in Oncology
  2. 2016
    NRG Oncology Outstanding ManuscriptNRG Oncology
  3. 2015
    NRG Oncology Outstanding AbstractNRG Oncology
  4. 2015
    Betty J. Foust, M.D. and Parents' ProfessorshipMayo Clinic
  5. 2014
    Award for Excellence in Adult Clinical ResearchAmerican Society for Neuro-Oncology
  6. 2011
    Best Doctors of 2011/Medical OncologyBest Doctors in America
  7. 2008
    DOM Residency - Top EducatorMayo Clinic in Rochester
  8. 2004
    Minority Medical Student Award - Nicole MarshallMayo Clinic College of Medicine and Science, Department of Education Administration
  9. 2003
    Mayo Awards for Excellence, Excellence Through TeamworkMayo Clinic
  10. 2001
    Award for Excellence in Clinical ResearchSociety for Neuro-Oncology
  11. 1976
    Magna Cum LaudeWake Forest University
  12. 1972
    Carswell ScholarWake Forest University

Professional memberships

  1. 2018
    Consultant ReviewerEORTC Independent Data Monitoring Committee
  2. 2016
    ReviewerNational Institutes of Health, National Cancer Institute, Subcommittee A - Cancer Centers, Dana-Farber/Harvard Cancer Center Site Visit
  3. 2016 - 2018
    ChairPractice Committee, Mayo Clinic Cancer Center IMP
  4. 2016 - present
    ChairExecutive Committee, Mayo Clinic Cancer Center IMP
  5. 2016 - present
    Vice ChairBoard of Directors, National Comprehensive Cancer Network
  6. 2016 - present
    ChairNational Comprehensive Cancer Network Governance Committee
  7. 2016
    Reviewer, Education BookAmerican Society of Clinical Oncology
  8. 2015 - 2016
    ContributorEuropean Society for Medical Oncology
  9. 2015 - 2016
    Co-ChairMayo Clinic Cancer Center Practice/Research Integration Task Force
  10. 2015
    Consultant ReviewerEORTC Independent Data Monitoring Committee
  11. 2015 - 2016
    ChairCancer Care Advisory Council Executive Committee
  12. 2014 - 2016
    Co-ChairCancer Care Delivery Research Coordinating Committee, National Cancer Institute, National Institutes of Health
  13. 2014
    PanelistNational Brain Tumor Society - Brain Tumor Clinical Trial Endpoints Workshop 2: Symptoms
  14. 2014 - present
    MemberBoard of Directors, National Comprehensive Cancer Network
  15. 2014 - present
    MemberGuidelines Panel Steering Committee, National Comprehensive Cancer Network
  16. 2014 - 2016
    Cancer Service Line External Review MemberStanford University
  17. 2014 - present
    MemberBoard of Directors, Alliance for Clinical Trials in Oncology Foundation
  18. 2014
    ChairCenter for Individualized Medicine Search Committee
  19. 2014 - 2016
    MemberExternal Advisory Board, Cure Brain Tumor Foundation (Australia)
  20. 2013 - 2016
    Cancer Care Advisory Council
  21. 2013
    ChairBrain Tumor Advisory Board, Genentech
  22. 2013 - 2016
    Task Force MemberNCI-AACR Cancer Patient Tobacco Use Assessment Task Force, National Cancer Institute, National Institutes of Health
  23. 2013 - 2015
    Panel MemberCNS Biomarker Reporting Panel, Cancer Biomarker Reporting Committee, College of American Pathologists
  24. 2012
    ChairBrain Tumor Advisory Board, Genentech
  25. 2012 - 2015
    ChairExternal Advisory Board, Brain Tumor Research Center, University of California, San Francisco
  26. 2012 - 2014
    MemberIT Oversight Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  27. 2012 - present
    ChairExecutive Committee, Department of Oncology
  28. 2012 - 2016
    MemberOperations and Management Committee, Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  29. 2012 - 2013
    Associate DirectorCooperative Group, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  30. 2011 - present
    Board MemberAcademic and Community Cancer Research United Consortium
  31. 2011 - 2014
    Co-InvestigatorBrain Tumor SPORE, Project 3
  32. 2011 - 2013
    ChairSteering Committee, Cancer Control Program, Alliance for Clinical Trials in Oncology
  33. 2011 - 2013
    MemberMembership Committee, Alliance for Clinical Trials in Oncology
  34. 2011 - 2013
    Executive Committee MemberNeuro-Oncology Committee, Alliance for Clinical Trials in Oncology
  35. 2011 - 2013
    MemberFinance Committee, Alliance for Clinical Trials in Oncology
  36. 2011 - 2013
    MemberIT Systems Committee, Alliance for Clinical Trials in Oncology
  37. 2011 - present
    Principal InvestigatorCancer Control Program, Alliance for Clinical Trials in Oncology
  38. 2011 - present
    ChairExecutive Committee, Cancer Control Program, Alliance for Clinical Trials in Oncology
  39. 2011 - present
    MemberBoard of Directors, Alliance for Clinical Trials in Oncology
  40. 2011 - present
    MemberExecutive Committee, Alliance for Clinical Trials in Oncology
  41. 2011 - present
    MemberProgram Operations Committee, Alliance for Clinical Trials in Oncology
  42. 2011 - present
    MemberStudy Concept Review Committee, Alliance for Clinical Trials in Oncology
  43. 2011 - present
    MemberPrevention Committee, Alliance for Clinical Trials in Oncology
  44. 2011 - present
    MemberSymptom Intervention Committee, Alliance for Clinical Trials in Oncology
  45. 2011 - present
    MemberHealth Outcomes Committee, Alliance for Clinical Trials in Oncology
  46. 2011 - present
    MemberHealth Disparities Committee, Alliance for Clinical Trials in Oncology
  47. 2011 - present
    MemberCancer in the Elderly Committee, Alliance for Clinical Trials in Oncology
  48. 2011 - present
    MemberCommunity Oncology Committee, Alliance for Clinical Trials in Oncology
  49. 2010
    ChairBrain Tumor Advisory Board, Genentech
  50. 2010 - 2012
    Co-ChairMCHS/MCR Oncology Council, Mayo Clinic Health System
  51. 2010 - 2014
    ChairCooperative Group Chairs, National Cancer Institute, National Institutes of Health
  52. 2009 - 2010
    Co-ChairTranslational Research Coordinating Committee, North Central Cancer Treatment Group, National Cancer Institute
  53. 2009 - 2010
    MemberOperations Efficiency Working Group, National Cancer Institute, National Institutes of Health
  54. 2009
    External AdvisorNeuro-oncology Program, Cleveland Clinic
  55. 2008
    ChairGlioblastoma Advisory Board, Genentech
  56. 2008 - 2016
    ReviewerAnnual Meeting Education Program, American Society of Clinical Oncology
  57. 2008 - 2015
    MemberExternal Advisory Board, Adult Brain Tumor Consortium
  58. 2008 - 2015
    ChairData Monitoring Committee, CENTRIC Trial, EMD Serono
  59. 2008 - 2015
    MemberData Safety & Monitoring Committee, CORE Trial, EMD Serono
  60. 2008 - 2014
    Medical DirectorCancer Center Systems Management Office, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  61. 2008 - 2011
    MemberEducation Products Subcommittee, American Society of Clinical Oncology
  62. 2008 - 2009
    MemberAdministrative Committee of the Executive Board, Mayo Clinic Rochester - Executive Board, Mayo Clinic Rochester Committees
  63. 2008
    ConsultantGlioblastoma Multiforme Advisory Board, Bristol-Myers Squibb
  64. 2007
    ChairGlioblastoma Advisory Board, Genentech
  65. 2007 - 2014
    MemberExternal Advisory Committee, National Foundation for Cancer Research
  66. 2007 - 2012
    MemberExternal Advisory Board, Pediatric Brain Tumor Consortium
  67. 2007 - 2011
    ConsultantNeoPharm, Inc.
  68. 2007 - 2010
    MemberClinical Trials Management System Steering Committee, Research Bioinformation Subcommittee, Research Committee
  69. 2007 - 2010
    Co-ChairClinical Trials Management System Steering Group, National Cancer Institute, National Institutes of Health
  70. 2007 - 2008
    MemberMarketing Committee, Mayo Clinic Rochester Committees
  71. 2007 - 2008
    MemberExternal Advisory Board, Brain Tumor Funders' Collaborative
  72. 2007 - present
    MemberZumbro Valley Medical Society, Minnesota Medical Association
  73. 2006 - 2007
    MemberMayo Intellectual Property Task Force, Mayo Clinic Task Forces/Work Groups
  74. 2006 - 2016
    AuthorASCO Self-Evaluation Program, American Society of Clinical Oncology
  75. 2006
    MemberExpert Panel, Patient-Reported Outcomes Assessment in Cancer Trials, Food and Drug Administration
  76. 2006
    MemberDepartment of Neuro-Oncology Review, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  77. 2006
    MemberBrain Tumor Program, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  78. 2006
    MemberCentral IRB Initiative Evaluation Panel, National Cancer Institute, National Institutes of Health
  79. 2006
    External Advisory Board, University of Texas M.D. Anderson Cancer Center
  80. 2006
    Advisory Board MemberAMG102 in Treatment of Glioblastoma Multiforme, Amgen, Inc.
  81. 2006 - 2015
    ReviewerASCO Self-Evaluation Program, American Society of Clinical Oncology
  82. 2006 - 2007
    ChairCNS Primary Brain Tumor Project Task Force, Clinical Practice Committee - Rochester, Mayo Clinic Rochester Committees
  83. 2006
    External AdvisorChildren's Oncology Group
  84. 2006
    PanelistBrain Tumor Endpoints Workshop, Food and Drug Administration
  85. 2005 - 2016
    MemberPhase III Concept Evaluation, Cancer Therapy Evaluation Program, National Cancer Institute
  86. 2005 - 2008
    MemberBrain Tumor Center SPORE Grant Review, External Advisory Board, University of Texas M.D. Anderson Cancer Center
  87. 2005
    MemberEnzastaurin, Review of Product Development, Food and Drug Administration
  88. 2004 - 2011
    ChairScientific Coordinators Committee, North Central Cancer Treatment Group, National Cancer Institute
  89. 2004
    MemberRSR-13, Review of Product Development, Food and Drug Administration
  90. 2004
    ConsultantEli Lilly and Company
  91. 2004
    MemberEli Lilly and Company
  92. 2004 - 2011
    ChairResearch Consoritum
  93. 2004
    Discussant - GliadelOncologic Drug Advisory Committee, Division of Oncology Drug Products, Center for Drug Evaluation and Research
  94. 2003 - 2006
    ConsultantAnti-Sense Pharma
  95. 2003 - 2004
    MemberMKSAP Development Team, American Society of Clinical Oncology
  96. 2002 - 2003
    MemberCommission on Cancer Work Group, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  97. 2002
    ReviewerNational Institutes of Health, National Cancer Institute, Subcommittee A - Cancer Centers, Johns Hopkins Sydney Kimmel Cancer Center Site Visit
  98. 2002
    MemberCNS Consortia, Special Study Section, National Cancer Institute
  99. 2002 - 2012
    MemberExternal Advisory Board, Brain Tumor Research Center, University of California, San Francisco
  100. 2002
    ModeratorResearch Recognition Dinner, American Brain Tumor Association
  101. 2002
    Site Visit ReviewerNew York University School of Medicine's Kaplan Comprehensive Cancer Center, National Cancer Institute, National Institutes of Health
  102. 2002 - 2014
    Site Visit ReviewerNeuro-Oncology Intramural Program, National Cancer Institute, National Institutes of Health
  103. 2002 - 2014
    MemberBoard of Directors, Coalition of National Cancer Cooperative Groups
  104. 2002 - 2014
    Principal InvestigatorNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  105. 2002 - 2011
    ChairConcept Review Committee, North Central Cancer Treatment Group, National Cancer Institute
  106. 2002 - 2006
    Member"Blood Brain Barrier Disruption in Brain Tumor Therapy", Portland, Oregon Special Review Committee, Site Visit Committee
  107. 2002 - 2014
    ChairNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  108. 2002 - 2014
    ChairAdministrative Committee, North Central Cancer Treatment Group, National Cancer Institute
  109. 2002 - 2012
    ChairExecutive Committee, Division of Medical Oncology, Department of Oncology
  110. 2001 - 2011
    Clinical Research Core DirectorBrain Tumor SPORE, Project 3
  111. 2001 - 2006
    MemberIT Oversight Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  112. 2001 - 2004
    ChairClinical and Populations Science Research Management Team (CAPERS)
  113. 2001 - 2004
    Program DirectorClinical Trials Program, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  114. 2001 - 2004
    ChairClinical Research Management Team, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  115. 2001
    ChairClinical Research Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  116. 2001 - 2003
    Co-ChairGonda Operations Team 10, Mayo Clinic Rochester Committees
  117. 2000 - 2016
    MemberScientific Advisory Council, American Brain Tumor Association
  118. 2000 - 2012
    MemberRegional Practice Task Group, Department of Oncology
  119. 2000
    ConsultantGlioblastoma Advisory Board, Genentech
  120. 2000
    MemberRound Table Discussion with Vice-President Al Gore, American Assocation of Retired Persons
  121. 1999 - 2001
    MemberTemozolomide, Review of Product Development, Schering-Plough Research Institute
  122. 1999
    MemberResonant Stress Response, Review of Product Development, Food and Drug Administration
  123. 1999
    ConsultantReview New Drug Application, Food and Drug Administration
  124. 1998 - 1999
    MemberCNS Tumors, Program Committee, American Society of Clinical Oncology
  125. 1998
    MemberHigh Cost Biotechnology Advisory Focus Group, Mayo Clinic Rochester Committees
  126. 1998
    Technical AdvisorPrimer of Brain Tumors, Seventh Edition, American Brain Tumor Association
  127. 1998
    EditorPrimer of Brain Tumors, Seventh Edition, American Brain Tumor Association
  128. 1998 - 1999
    MemberOutreach Work Group, Regional Operations Committee, Mayo Clinic Health System
  129. 1998
    DiscussantAd Hoc Discussion of Issues Important to Seniors, Cancer Clinical Trials
  130. 1998
    MemberGadolinium Texaphyrin, Review of Product Development, Food and Drug Administration
  131. 1998
    MemberDibromodulcitol, Review of Product Development, Food and Drug Administration
  132. 1998 - 2003
    Vice ChairPractice Integration Facility Subcommittee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  133. 1998 - 1999
    MemberRegional Operations Committee, Mayo Clinic Health System
  134. 1997 - 1998
    MemberHead and Neck and CNS Tumors, Program Committee, American Society of Clinical Oncology
  135. 1997 - 1999
    MemberBoard of Directors, Society for Neuro-Oncology
  136. 1997 - 1998
    Co-ChairThird Annual Meeting, Society for Neuro-Oncology
  137. 1997 - 1998
    MemberScientific Program Committee, Society for Neuro-Oncology
  138. 1997
    MemberSU101, Review of Product Development, Food and Drug Administration
  139. 1997
    ConsultantWyeth-Ayerst
  140. 1997
    MemberCCI-779, Review of Product Development, Wyeth-Ayerst
  141. 1997
    ConsultantSchering-Plough Research Institute
  142. 1997
    MemberNominations Committee, Society for Neuro-Oncology
  143. 1997
    MemberFacilities and Social Events Committee, First Scientific Meeting, Society for Neuro-Oncology
  144. 1997
    Co-ChairCooperative Group Process Improvement Subcommittee, Operations Efficiency Working Group, National Cancer Institute
  145. 1997
    ConsultantCommon Toxicity Criteria Revision Meeting, Cancer Therapy Evaluation Program, National Cancer Institute
  146. 1997
    ChairSite Visit Team, Subcommittee D - Clinical Studies, National Cancer Institute
  147. 1997
    SWOG Site VisitSubcommittee H, National Cancer Institute, National Institutes of Health
  148. 1996
    ChairBy-Laws Committee, Society for Neuro-Oncology
  149. 1996
    Technical AdvisorPrimer of Brain Tumors, Sixth Edition, American Brain Tumor Association
  150. 1996
    EditorPrimer of Brain Tumors, Sixth Edition, American Brain Tumor Association
  151. 1996
    Discussant - TemozolomideOncologic Drug Advisory Committee, Division of Oncology Drug Products, Center for Drug Evaluation and Research
  152. 1995 - 1999
    Secretary/TreasurerSociety for Neuro-Oncology
  153. 1995 - 1996
    ChairData Safety Committee, Alkermes
  154. 1995 - 2002
    ChairClinical Practice Committee, Division of Medical Oncology, Department of Oncology
  155. 1995 - 2002
    MemberExecutive Committee, North Central Cancer Treatment Group, National Cancer Institute
  156. 1995 - 2002
    MemberPractice Guidelines Work Group, Division of Medical Oncology, Department of Oncology
  157. 1995 - 2001
    ChairData Monitoring Committee, North Central Cancer Treatment Group, National Cancer Institute
  158. 1995
    MemberSubcommittee on Guidelines for Medical Oncology Fellowship, American Society of Clinical Oncology
  159. 1995 - present
    MemberExecutive Committee, Division of Medical Oncology, Department of Oncology
  160. 1995 - present
    MemberSociety for Neuro-Oncology
  161. 1994 - 2000
    Program DirectorCancer Treatment, North Central Cancer Treatment Group, National Cancer Institute
  162. 1994 - 1998
    MemberOncology Research Review Committee, Mayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center
  163. 1994 - 1998
    MemberInternal Medicine Practice Committee, Department of Internal Medicine
  164. 1994 - 2002
    Vice ChairNorth Central Cancer Treatment Group, National Cancer Institute, National Institutes of Health
  165. 1994 - 1996
    MemberAdministrative Committee, North Central Cancer Treatment Group, National Cancer Institute
  166. 1993 - 2005
    MemberProgram Committee, American Society of Clinical Oncology
  167. 1993
    ReviewerSite Visit Committee, National Institutes of Health
  168. 1993
    Ad Hoc MemberSubcommittee H, National Cancer Institute, National Institutes of Health
  169. 1993
    MemberPortland, Oregon Special Review Committee, Site Visit Committee, National Institutes of Health
  170. 1993 - 2002
    DirectorNeuro-Oncology Program, North Central Cancer Treatment Group, National Cancer Institute
  171. 1993 - 1995
    MemberCurriculum Committee, Patient Physician, and Society, Mayo Medical School, Mayo Clinic College of Medicine and Science
  172. 1992
    MemberHumanities in Medicine Committee, Rochester Center for Humanities in Medicine, Mayo Clinic Center for Humanities in Medicine
  173. 1992 - 1994
    ChairHuman Values in Medicine Curriculum Committee, Mayo Medical School, Mayo Clinic College of Medicine and Science
  174. 1992
    MemberFourth Year Curriculum Committee, Mayo Medical School, Mayo Clinic College of Medicine and Science
  175. 1989
    MemberAd Hoc Committee on Medical Oncology Fellowship Training, American Society of Clinical Oncology
  176. 1989 - present
    FellowAmerican College of Physicians
  177. 1989 - 1991
    MemberDevelopment Liaison Committee, Mayo Clinic Rochester Committees
  178. 1988 - present
    MemberAmerican Association for Cancer Research
  179. 1987 - 1994
    MemberInternal Medicine and Medical Subspecialties, Graduate Education Committee, Mayo Foundation for Medical Education and Research
  180. 1987 - 1991
    MemberMedical and Laboratory Specialties, Graduate Education Committee, Mayo Foundation for Medical Education and Research
  181. 1986 - 1994
    ChairEducation Committee, Division of Medical Oncology, Department of Oncology
  182. 1986 - 1994
    Program DirectorMedical Oncology Training Program, Division of Medical Oncology, Department of Oncology
  183. 1986 - 2016
    MemberAmerican Medical Association
  184. 1986 - 2016
    ConsultantMedical Education Systems, Inc.
  185. 1986 - present
    MemberMinnesota Medical Association
  186. 1985 - 1993
    MemberMayo Clinic Membership, North Central Cancer Treatment Group, National Cancer Institute
  187. 1985 - 1993
    Scientific CoordinatorNeuro-Oncology Program, North Central Cancer Treatment Group, National Cancer Institute
  188. 1985 - present
    MemberAmerican Society of Clinical Oncology
  189. 1984 - 1985
    FellowAmerican Cancer Society
  190. 1976 - present
    MemberPhi Beta Kappa Honor Society
  191.  
    ConsultantReview of Product Development, Food and Drug Administration
  192.  
    MemberLung and CNS Tumors, Program Committee, American Society of Clinical Oncology
see more

Publications

Research activities

See a description of research activities.